Congress weighs in on PET coverage
This article was originally published in The Gray Sheet
Executive Summary
CMS should leave to local carrier discretion the coverage policy for positron emission tomography to diagnose pancreatic, brain, small cell lung, cervical, testicular and multiple myeloma cancers, Senate Cancer Coalition Co-Chairs Diane Feinstein (D-Calif.) and Sam Brownback (R-Kan.) advise in April 29 letter. Thirty-five other senators signed the missive. A decision on the indications, excluding multiple myeloma, was due April 12...
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.